$1.11 0.03 (+2.78%)
11/27/2009 12:59 PM

CombinatoRx, Inc. (CRXX)

CAPS Rating: 5 out of 5

A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals, with a portfolio of product candidates in phase 2 clinical development.

Results 1 - 10 of 10

Recs

1
Member Avatar thecyberguy (60.64) Submitted: 6/5/2008 2:37:32 PM : Underperform Start Price: $3.85 CRXX Score: +52.50

Who??

Recs

1
Member Avatar Cosmo21 (< 20) Submitted: 4/1/2008 6:11:02 PM : Outperform Start Price: $3.21 CRXX Score: -48.20

CRXX has a great pipeline and plenty of cash. Just a matter of time untill one of it's many phase II drugs is approved and a partner moves in. Buy now before it.s to late!

Recs

1
Member Avatar zzlangerhans (99.57) Submitted: 3/17/2008 11:46:40 AM : Outperform Start Price: $3.90 CRXX Score: -60.92

Another small-cap biotech knocked down to an all-time low in the absence of clear negative catalysts. Their pipeline appears to be proceeding well with encouraging phase II data for CRx-191 in psoriasis, and several other phase II trials in progress. The generic combo concept seems a little bargain basement, but the upside potential of new treatments for common diseases such as arthritis and diabetes cannot be ignored - witness the mad overreaction Rigel got with phase II data. Financials also appear strong with cash position more than 100M and a manageable burn. Eeventually this worm will turn and beaten down baby biotechs will recover.

Recs

0
Member Avatar Biotech2008 (84.88) Submitted: 1/4/2008 10:03:24 PM : Outperform Start Price: $4.33 CRXX Score: -54.89

stratton6 @ 4.94

Recs

1
Member Avatar stratton6 (98.89) Submitted: 12/7/2007 10:44:56 AM : Outperform Start Price: $5.43 CRXX Score: -55.67

Recently saw one of their presentations. Seems like they have a reasonable platform that is highly partnerable.

Recs

0
Member Avatar bnjguy8 (< 20) Submitted: 6/25/2007 9:48:43 PM : Outperform Start Price: $6.13 CRXX Score: -58.68

6 drugs in phase 2 ...time to get it is now...

Recs

0
Member Avatar spbanalytics (< 20) Submitted: 6/20/2007 10:21:12 AM : Outperform Start Price: $6.01 CRXX Score: -56.94

Very strong pipeline currently not priced in. High degree of probability for approvals based on test results so far, but approvals still a ways out.

Recs

0
Member Avatar ShuntSD (95.00) Submitted: 11/17/2006 1:00:27 PM : Outperform Start Price: $9.36 CRXX Score: -71.28

Taking a flyer on a young research pharm company. Solid management, cutting edge techology/research. Like all early pharms has risk but I think this one has huge upside.

Recs

0
Member Avatar BullRunSurfer (< 20) Submitted: 10/18/2006 1:29:38 PM : Outperform Start Price: $7.44 CRXX Score: -70.06

Look for a double

Recs

0
Member Avatar RBBioContest06 (30.97) Submitted: 5/31/2006 10:46:38 PM : Outperform Start Price: $8.21 CRXX Score: -78.57

Picked by patelketan

Results 1 - 10 of 10

Featured Broker Partners